TAMPA, FL, UNITED STATES, April 30, 2026 /EINPresswire.com/ — San Rocco Therapeutics (SRT) today announced two abstracts at the upcoming 2026 ASGCT Annual Meeting ...
The UK’s regulator has approved the world’s first CRISPR–Cas9 gene editing therapy, which aims to cure sickle cell disease and transfusion-dependent β-thalassemia. Casgevy (exagamglogene autotemcel) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results